Evidence map›Paper›PMID 26930558›Full record

ArticlePloS one2016

Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1.

Matthew J Robson, Chong-Bin Zhu, Meagan A Quinlan, David A Botschner, Nicole L Baganz, Kathryn M Lindler, Jason G Thome, William A Hewlett, Randy D Blakely

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Fibroblasts resistScience advances · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Ivermectin modulated cerebral γ-aminobutyric acid (GABA) and reduced the number of chronicJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2023
    Article
  14. Article
  15. Article
  16. IL-1 Receptor-1 onBrain, behavior, & immunity - health · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Matthew J RobsonDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Chong-Bin ZhuDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Meagan A QuinlanDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
David A BotschnerDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Nicole L BaganzDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Kathryn M LindlerDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Jason G ThomeDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
William A HewlettInstitute for Psychiatric Neuroscience, Nashville, Tennessee, United States of America.
Randy D BlakelyDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Vanderbilt University · US

Funding

Stress-Mediated Alterations in Serotonin 2C Receptor Editing and FunctionP50MH096972 · NIMH · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 2012 to 2016
$10.5M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Regulation of Serotonin TransportersR01MH094527 · NIMH · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 2011 to 2021
$4.4M
TRAINING PROGRAM IN ION CHANNEL AND TRANSPORTER BIOLOGYT32NS007491 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DENTON, JEROD S. · 2001 to 2020
$4.1M
Interleukin-1 (IL-1) Receptor-Mediated Modulation of Serotonin TransportersR21MH086033 · NIMH · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 2010 to 2011
$426k
NICHD NIH HHS U54 HD083211NIMH NIH HHS MH086033NIMH NIH HHS MH094527NIMH NIH HHS MH096972NIMH NIH HHS P50 MH096972NIMH NIH HHS R01 MH094527NIMH NIH HHS R21 MH086033NINDS NIH HHS T32 NS007491
6 · The paper itself

Abstract

The cytokines IL-1α and IL-1β exert powerful pro-inflammatory actions throughout the body, mediated primarily by the intracellular signaling capacity of the interleukin-1 receptor (IL-1R1). Although Il1r1 knockout mice have been informative with respect to a requirement for IL-1R1 signaling in inflammatory events, the constitutive nature of gene elimination has limited their utility in the assessment of temporal and spatial patterns of cytokine action. To pursue such questions, we have generated C57Bl/6J mice containing a floxed Il1r1 gene (Il1r1loxP/loxP), with loxP sites positioned to flank exons 3 and 4 and thereby the ability to spatially and temporally eliminate Il1r1 expression and signaling. We found that Il1r1loxP/loxP mice breed normally and exhibit no gross physical or behavioral phenotypes. Moreover, Il1r1loxP/loxP mice exhibit normal IL-1R1 receptor expression in brain and spleen, as well as normal IL-1R1-dependent increases in serum IL-6 following IL-1α injections. Breeding of Il1r1loxP/loxP mice to animals expressing a cytomegalovirus (CMV)-driven Cre recombinase afforded efficient excision at the Il1r1 locus. The Il1r1loxP/loxP line should be a valuable tool for the assessment of contributions made by IL-1R1 signaling in diverse cell types across development.

Indexed as

AllelesAnimalsBrainInterleukin-1alphaInterleukin-1betaMiceMice, TransgenicReceptors, Interleukin-1 Type ISignal TransductionInterleukin-1alphaInterleukin-1betaReceptors, Interleukin-1 Type I

Identifiers

PMID26930558
PMCPMC4773179
OpenAlexW2294380817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.